drugset / Trial / NCT02686645
Fecal Microbiota Therapy for Recurrent Clostridium Difficile Infection
NaSingle-groupOpen-labelTreatment
Summary
Interventional, single arm, single-centre trial to evaluate the effectiveness and safety of fecal microbiota therapy (FMT) in the investigators population.
Timeline
- Start
- 2016-12
- Primary completion
- 2021-12
- Completion
- 2021-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fecal Microbiota | Other / unclassified | — | Rectal |
| Background | Loperamide | Small molecule | 4 mg | Oral |
| Background | Metronidazole | Small molecule | 500 mg | Oral |
| Background | Vancomycin | Other / unclassified | 125 mg | Oral |